Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
eNq1mFFv2jAQx9/5FFHeSQgtbZkC1cZgQ2o1Ros27aUyyQFmwU7PNtB9+jmEbnRy1NXgx9jO/86+u59Pjq+3q8xbAwrKWcePgobvAUt4Stm840/uB/Ur/7pbi5dkTQ6WXQaNIGr6XpIRITp+MRtMgTARfL+9+Qj6f0C/W/NiPl1CIl+sU5JmwWciFrckL9Z48ZrT1FuBXPC04+dK7ka9WEjUXnQ3HH+KnCQQh/uRw9nlw/nheBwWYv+hqgTgDWFzoygwK81EIQKTPSJhzvGpwt8zK20qxiC4wgRGRC5GyNc0hdRoYkYyAVZGZpv0DnCdgSyMGMXDZbISVuJkSbZjeByanX6vZ3tyK+uNenR52b44P281o1ajbWUKD47KHAW9iTB5iBqNdqt5FgIL11QQxsAyNiOOkmSOokJF72ViObKD8Phq9FMq8ow8BUuR2x4VQaKnAXX5u9tIsYN71EDK9Jn9o89UloVv9Hqyx4Ujjwsa9bhisoIag7HtQfQ4k7Ctjqgd6OR2n4sUxOlkf3FmhvxITTOa2CJNQ0eBkJPxsJpop4TBByJggu5o8I2ylG/E6SlzGFVH3uc7UBpFc0yjh2b76iJqtayL6IdOoYobpq+Q5xBq/lBxDFaGbMaPBYrOSrPUc06eLB13fQ5PSAYVnU7dki06D58bM2eZ7q6Kygmj6Kf+vW16fFWAT3e7T6M0TTt/AmsHXhc018lY6fjbU7uscCc9sEIzORZS5uJdGG42m2BBRF1Xi4Rghicn+8Fl6q4Dd3Jjlx1MSUdHrk/La+9tEbKttNfu9GP71P3/+37YaEOigiNiUULZGTqH/dPT+G+T6szt0Qt6uDOzayiJpJy5anTU1Kh4HP91XNkANSC+zGa04kWkMi/jsHyN6dbisHiJ6dZ+AxOU5Jo=
gRSE5HSYpRgwUBKB
